1. Build the clinical timeline
Review symptoms, diagnoses, hospital care, medicines, adherence, side effects, substance use, medical history, supports, and current functioning.
Schizophrenia treatment can combine antipsychotic medicine, psychological and family support, and help with daily activities. A long-acting injection may suit a person’s preference or difficulty taking tablets, but it is not automatically the best option. Products differ in indication, route, interval and start rules. Prescribing, administration, monitoring and ongoing psychiatric care must stay connected. The longest interval is not a first-step choice for everyone. Treatment-resistant illness may warrant a clozapine assessment rather than another routine injection change.
Schizophrenia care can combine antipsychotic medicine with psychotherapy, family education, practical support and help with daily activities. Some antipsychotics are available as long-acting injections. An injection can be useful when a person prefers that form or has difficulty with daily medicine, but it is not automatically the best choice. A medication programme should connect prescribing, administration and continuing psychiatric care.
Antipsychotics affect brain receptor systems involved in psychosis. A long-acting formulation gradually releases medicine after an injection. Different products use different ingredients, routes, intervals and release patterns. Some need oral medicine at the start, some use an initiation sequence and some require previous stabilization on a shorter-interval injection. These differences determine the safe plan.
The psychiatrist reviews diagnosis, previous response, tolerability, physical health, preferences and practical needs. The indication differs by product: some cover adult schizophrenia only; others have specific schizoaffective or bipolar maintenance indications. The longest dosing interval is not a first-step option for every patient. Treatment-resistant schizophrenia may call for a clozapine assessment rather than another routine injection change.
Discuss daily-pill difficulties, benefits, adverse effects, injection preferences, work and transport. Review the actual label, prior trials and alternatives without treating an injection as a reward or punishment.
The administering team needs the exact product, strength, last date, route, oral coverage and responsible prescriber. A discharge note saying “monthly antipsychotic” is insufficient. Resolve product delivery and any late-dose plan before the appointment.
Record what was given and when the next dose is due. Share the record with the prescribing clinician. Continuing reviews cover symptoms, daily function, movement effects, metabolic health, prolactin where relevant and psychosocial needs.
Bring the exact product name, prescribed strength, last injection date, oral medicine list and the responsible prescriber’s contact information. Include discharge notes, recent blood tests and any written start or restart plan. Tell the team about pregnancy, breastfeeding, allergies, seizures, fainting, substance use and new medicines or supplements. If a dose is delayed or records are unclear, contact the prescriber before travelling to an administration visit. Discuss who can help with appointment reminders or transport if you want that support. Ask how consent, preferences and questions about a longer-lasting treatment will be addressed.
Antipsychotics have a boxed warning about increased mortality in older adults with dementia-related psychosis. Product-specific risks include movement symptoms, sedation, falls, weight and metabolic changes, prolactin effects and sometimes heart-rhythm concerns. Effects of a depot cannot be immediately removed after an injection. Seek emergency care for severe trouble breathing, throat or tongue swelling, loss of consciousness, or high fever with severe muscle stiffness and confusion. Contact the treating team promptly for new involuntary movements, severe restlessness, worsening psychosis, marked dizziness or troublesome injection-site symptoms. Do not wait for the next routine injection to report a serious concern. Report worsening psychosis or safety concerns promptly rather than waiting for the injection date.
Arrange both injection appointments and psychiatric reviews. If a dose may be missed, contact the responsible prescriber with the exact product, strength and last date. Restart rules vary. Report side effects between doses. Ask about therapy, family support, housing, work or coordinated specialty care when relevant. A reliable injection schedule is one part of a broader care plan.
Before an injection appointment, ask which clinic can accept the prescription, how the medicine will be obtained, and which costs belong to the medicine, administration and psychiatry follow-up. A benefits check, prior authorization and medicine delivery are different steps. Ask for the proposed cost before each step. Manufacturer assistance has its own eligibility rules. Office-visit coverage does not establish medication coverage, and a listed clinic does not establish that the product is stocked or can be given there today. Confirm whether Nao is providing prescribing, administration under an outside order or both. The responsibilities and records should be clear before transfer of care.
An appropriate evaluation or follow-up may be possible by video when the clinician is authorized to treat you where you are physically located. The service must confirm age, eligibility and current prescribing requirements. A video visit does not guarantee a controlled-substance prescription. Some examinations and tests need an in-person visit. Provider-administered injections require the appropriate treatment setting. Ask intake where any ordered specimens must be collected. Tell intake your actual location and requested service.
The psychiatrist reviews diagnosis, previous response, tolerability, physical health, preferences and practical needs. The indication differs by product: some cover adult schizophrenia only; others have specific schizoaffective or bipolar maintenance indications. The longest dosing interval is not a first-step option for every patient. Treatment-resistant schizophrenia may call for a clozapine assessment rather than another routine injection change.
Discuss daily-pill difficulties, benefits, adverse effects, injection preferences, work and transport. Review the actual label, prior trials and alternatives without treating an injection as a reward or punishment.
The administering team needs the exact product, strength, last date, route, oral coverage and responsible prescriber. A discharge note saying “monthly antipsychotic” is insufficient. Resolve product delivery and any late-dose plan before the appointment.
Record what was given and when the next dose is due. Share the record with the prescribing clinician. Continuing reviews cover symptoms, daily function, movement effects, metabolic health, prolactin where relevant and psychosocial needs.
Antipsychotics have a boxed warning about increased mortality in older adults with dementia-related psychosis. Product-specific risks include movement symptoms, sedation, falls, weight and metabolic changes, prolactin effects and sometimes heart-rhythm concerns. Effects of a depot cannot be immediately removed after an injection. Seek emergency care for severe trouble breathing, throat or tongue swelling, loss of consciousness, or high fever with severe muscle stiffness and confusion. Contact the treating team promptly for new involuntary movements, severe restlessness, worsening psychosis, marked dizziness or troublesome injection-site symptoms. Do not wait for the next routine injection to report a serious concern. Report worsening psychosis or safety concerns promptly rather than waiting for the injection date.
Arrange both injection appointments and psychiatric reviews. If a dose may be missed, contact the responsible prescriber with the exact product, strength and last date. Restart rules vary. Report side effects between doses. Ask about therapy, family support, housing, work or coordinated specialty care when relevant. A reliable injection schedule is one part of a broader care plan.
A partner or other support person can join with your agreement when the service permits it. Discuss what you want shared and how they can help with sleep, transport, infant care and safety. Their involvement does not replace your own confidential assessment. Tell the clinician if support is unavailable or the relationship itself feels unsafe.
No. The clinician must assess the diagnosis, current medicines, symptoms, risks, records and prescribing requirements before deciding on treatment. Paying for or booking an evaluation does not guarantee a stimulant, benzodiazepine, Spravato or any specific prescription. If an existing medicine may run out, tell the current prescriber and intake promptly rather than abruptly stopping it.
Use emergency care for an immediate threat to safety, severe confusion, inability to care safely for yourself, or dangerous manic/psychotic symptoms. Call 911 for immediate danger. An online medication-management appointment is not an emergency service. For non-immediate worsening, contact the treating clinician promptly and describe symptoms and medication gaps.
Schizophrenia is a serious mental illness that can affect thinking, perception, emotion and daily functioning. Psychotic symptoms can include hearing or seeing things others do not, firmly held beliefs that do not match reality, or disorganized thought and speech. Some people also have reduced motivation or emotional expression and difficulties with attention or memory. Assessment considers other possible causes of psychosis. Treatment can improve symptoms and functioning; the diagnosis does not define a person’s ability to recover or their worth.
Schizophrenia has multiple contributors, rather than five proven causes that apply to everyone. Many genes can affect risk, but no single gene causes it and having an affected relative does not make it inevitable. Environmental and life experiences, exposures before birth, and brain structure or function may also play a role. These are risk contributors, not a way to diagnose yourself or blame a parent. A clinical assessment and early treatment are more useful than trying to identify one cause.
Current treatment focuses on managing symptoms, preventing relapse and improving daily life; it does not offer a guaranteed permanent cure. Many people improve substantially with care that can combine antipsychotic medication, psychotherapy, family support and practical services. Recovery can include work, school, relationships and independence. Continue the agreed plan when symptoms improve, and discuss changes with the treating team rather than stopping medicine yourself.
Review symptoms, diagnoses, hospital care, medicines, adherence, side effects, substance use, medical history, supports, and current functioning.
Evaluate suicide or violence risk, command hallucinations, severe disorganization, catatonia, self-care, housing, access to food, and ability to follow an outpatient plan.
Set target symptoms and functional goals, discuss reasonable options, arrange baseline checks, and document side-effect and response measures.
Confirm refills, laboratory work, primary care, psychotherapy and support services, emergency contacts, early warning signs, and the next review.
Bronx
932 E 174th St, Bronx, NY 10460
Start with the dedicated virtual psychiatry route. This nearby Nao clinic may support separately ordered physical care only when the psychiatric and clinic teams confirm the need.
Queens
37-15 23rd Ave, Astoria, NY 11105
Start with the dedicated virtual psychiatry route. This nearby Nao clinic may support separately ordered physical care only when the psychiatric and clinic teams confirm the need.
Bronx
2063A Bartow Ave, Bronx, NY 10475
Start with the dedicated virtual psychiatry route. This nearby Nao clinic may support separately ordered physical care only when the psychiatric and clinic teams confirm the need.
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
Start with the dedicated virtual psychiatry route. This nearby Nao clinic may support separately ordered physical care only when the psychiatric and clinic teams confirm the need.
Long Island
232 W Old Country Rd, Hicksville, NY 11801
Start with the dedicated virtual psychiatry route. This nearby Nao clinic may support separately ordered physical care only when the psychiatric and clinic teams confirm the need.
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
Start with the dedicated virtual psychiatry route. This nearby Nao clinic may support separately ordered physical care only when the psychiatric and clinic teams confirm the need.
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
Start with the dedicated virtual psychiatry route. This nearby Nao clinic may support separately ordered physical care only when the psychiatric and clinic teams confirm the need.
Queens
30-07 36th Ave, Astoria, NY 11106
Start with the dedicated virtual psychiatry route. This nearby Nao clinic may support separately ordered physical care only when the psychiatric and clinic teams confirm the need.
Long Island
135 Mineola Blvd, Mineola, NY 11501
Start with the dedicated virtual psychiatry route. This nearby Nao clinic may support separately ordered physical care only when the psychiatric and clinic teams confirm the need.
Manhattan
259 1st Ave, New York, NY 10003
Start with the dedicated virtual psychiatry route. This nearby Nao clinic may support separately ordered physical care only when the psychiatric and clinic teams confirm the need.
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
Start with the dedicated virtual psychiatry route. This nearby Nao clinic may support separately ordered physical care only when the psychiatric and clinic teams confirm the need.
Review the evaluation, outside-order, medication-delivery, site, and administration pathway.
Review current ANC monitoring, titration, interaction, and continuity requirements.
Review the broader medication, interaction, monitoring, and follow-up framework.
Review the one-time Aristada initiation regimen and its separate coordination requirements.
Book a general psychiatric evaluation when schizophrenia medication care is not the primary question.
American Psychiatric Association
Assessment, antipsychotic treatment, long-acting medicines, clozapine, and monitoring.
Open official sourceAmerican Psychiatric Association
Psychiatric, treatment, substance-use, medical, safety, and shared-decision assessment.
Open official sourceU.S. Food and Drug Administration
Current active REMS status and official program materials.
Open official source